Immunopathogenesis and perspectives for immunotherapy of coronavirus infection
Open Access
- 9 February 2021
- journal article
- review article
- Published by Baltic Medical Education Center in HIV Infection and Immunosuppressive Disorders
- Vol. 12 (4) , 7-22
Abstract
Highly pathogenic coronavirus SARS-CoV-2 is the cause of COVID-19 in humans sometimes with severe clinical manifestations and death. COVID-19 immunopathogenesis is linked with dysregulated immune response with decreased interferon synthesis at the beginning of infection followed by inflammatory cytokines hyperproduction, resulting in an exuberant lung inflammation and respiratory distress syndrome. Perspective immunotherapy directions for COVID-19 could be: intranasal recombinant interferon application in the initial stage of disease, anticytokine therapy at the stage of severe pneumonia and cytokine storm development, passive immunization with blood plasma of recovered patients or therapeutic monoclonal antibodies, prophylactic vaccination.Keywords
This publication has 84 references indexed in Scilit:
- Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2Cell, 2020
- Pathological findings of COVID-19 associated with acute respiratory distress syndromeThe Lancet Respiratory Medicine, 2020
- Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoVNature Communications, 2020
- A new coronavirus associated with human respiratory disease in ChinaNature, 2020
- A pneumonia outbreak associated with a new coronavirus of probable bat originNature, 2020
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, ChinaThe Lancet, 2020
- An NFκB Activity Calculator to Delineate Signaling Crosstalk: Type I and II Interferons Enhance NFκB via Distinct MechanismsFrontiers in Immunology, 2019
- Regulating IRFs in IFN Driven DiseaseFrontiers in Immunology, 2019
- Genetic Variation of the Human α-2-Heremans-Schmid Glycoprotein (AHSG) Gene Associated with the Risk of SARS-CoV InfectionPLOS ONE, 2011
- Pattern Recognition Receptors and InflammationCell, 2010